These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17997080)

  • 21. Discovery of 4-Pyridone derivatives as specific inhibitors of enoyl-acyl carrier protein reductase (FabI) with antibacterial activity against Staphylococcus aureus.
    Takahata S; Iida M; Yoshida T; Kumura K; Kitagawa H; Hoshiko S
    J Antibiot (Tokyo); 2007 Feb; 60(2):123-8. PubMed ID: 17420562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of mutational resistance to trimethoprim in Staphylococcus aureus by genetic and structural modelling techniques.
    Vickers AA; Potter NJ; Fishwick CW; Chopra I; O'Neill AJ
    J Antimicrob Chemother; 2009 Jun; 63(6):1112-7. PubMed ID: 19383727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of bacterial biocide and antibiotic resistance.
    Poole K
    J Appl Microbiol; 2002; 92 Suppl():55S-64S. PubMed ID: 12000613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus.
    Kalia NP; Mahajan P; Mehra R; Nargotra A; Sharma JP; Koul S; Khan IA
    J Antimicrob Chemother; 2012 Oct; 67(10):2401-8. PubMed ID: 22807321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of resistance to quinolones.
    Jacoby GA
    Clin Infect Dis; 2005 Jul; 41 Suppl 2():S120-6. PubMed ID: 15942878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of GrlA mutation on the development of quinolone resistance in Staphylococcus aureus in an in vitro pharmacokinetic model.
    Oonishi Y; Mitsuyama J; Yamaguchi K
    J Antimicrob Chemother; 2007 Nov; 60(5):1030-7. PubMed ID: 17827137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?
    Gilbert P; Allison DG; McBain AJ
    J Appl Microbiol; 2002; 92 Suppl():98S-110S. PubMed ID: 12000619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel inhibitory activity of the Staphylococcus aureus NorA efflux pump by a kaempferol rhamnoside isolated from Persea lingue Nees.
    Holler JG; Christensen SB; Slotved HC; Rasmussen HB; Gúzman A; Olsen CE; Petersen B; Mølgaard P
    J Antimicrob Chemother; 2012 May; 67(5):1138-44. PubMed ID: 22311936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles.
    Holler JG; Slotved HC; Mølgaard P; Olsen CE; Christensen SB
    Bioorg Med Chem; 2012 Jul; 20(14):4514-21. PubMed ID: 22682300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efflux genes and active efflux activity detection in Malaysian clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
    Saiful AJ; Mastura M; Zarizal S; Mazurah MI; Shuhaimi M; Ali AM
    J Basic Microbiol; 2008 Aug; 48(4):245-51. PubMed ID: 18720500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triclosan-tolerant bacteria: changes in susceptibility to antibiotics.
    Cottell A; Denyer SP; Hanlon GW; Ochs D; Maillard JY
    J Hosp Infect; 2009 May; 72(1):71-6. PubMed ID: 19246121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of triclosan on Salmonella typhimurium at different growth stages and in biofilms.
    Tabak M; Scher K; Hartog E; Romling U; Matthews KR; Chikindas ML; Yaron S
    FEMS Microbiol Lett; 2007 Feb; 267(2):200-6. PubMed ID: 17156099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indirubin potentiates ciprofloxacin activity in the NorA efflux pump of Staphylococcus aureus.
    Ponnusamy K; Ramasamy M; Savarimuthu I; Paulraj MG
    Scand J Infect Dis; 2010 Jul; 42(6-7):500-5. PubMed ID: 20380543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of substrate exposure and other growth condition manipulations on norA expression.
    Kaatz GW; Seo SM
    J Antimicrob Chemother; 2004 Aug; 54(2):364-9. PubMed ID: 15231765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global transcriptional profiles of Staphylococcus aureus treated with berberine chloride.
    Wang D; Yu L; Xiang H; Fan J; He L; Guo N; Feng H; Deng X
    FEMS Microbiol Lett; 2008 Feb; 279(2):217-25. PubMed ID: 18179590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substituted dihydronaphthalenes as efflux pump inhibitors of Staphylococcus aureus.
    Thota N; Reddy MV; Kumar A; Khan IA; Sangwan PL; Kalia NP; Koul JL; Koul S
    Eur J Med Chem; 2010 Sep; 45(9):3607-16. PubMed ID: 20605275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus.
    Khan IA; Mirza ZM; Kumar A; Verma V; Qazi GN
    Antimicrob Agents Chemother; 2006 Feb; 50(2):810-2. PubMed ID: 16436753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance to fluoroquinolones by the combination of target site mutations and enhanced expression of genes for efflux pumps in Shigella flexneri and Shigella sonnei strains isolated in Korea.
    Kim JY; Kim SH; Jeon SM; Park MS; Rhie HG; Lee BK
    Clin Microbiol Infect; 2008 Aug; 14(8):760-5. PubMed ID: 18727800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triclosan and antibiotic resistance in Staphylococcus aureus.
    Suller MT; Russell AD
    J Antimicrob Chemother; 2000 Jul; 46(1):11-8. PubMed ID: 10882683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.